Functional genomics studied by proteomics

BioEssays

Volumn 26, Issue 8, 2004, Pages 901-915

  Honoré, Bent ^a   Østergaard, Morten ^a   Vorum, Henrik ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ANIMAL CELL; DNA MICROARRAY; GENETIC TRANSCRIPTION; GENOME ANALYSIS; GENOMICS; GLYCOSYLATION; NONHUMAN; PHAGE DISPLAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; REPRODUCIBILITY; REVIEW;

DATABASES, FACTUAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENOMICS; HUMANS; MASS SPECTROMETRY; PEPTIDE LIBRARY; PROTEIN ARRAY ANALYSIS; PROTEOMICS; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 4344617838     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20075     Document Type: Review

References (109)

1. Collins FS, Green ED, Guttmacher AE, Guyer MS. 2003. A vision for the future of genomics research. Nature 422:835-847.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
3. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. 2001. The Sequence of the Human Genome. Science 291:1304-1351.
4. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, et al. 2003. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141-2144.
5. Honoré B. 2001. Genome- and proteome-based technologies: status and applications in the postgenomic era. Expert Rev Mol Diagn 1:265-274.
6. Pradet-Balade B, Boulme F, Beug H, Mullner EW, Garcia-Sanz JA. 2001. Translation control: bridging the gap between genomics and proteomics? Trends Biochem Sci 26:225-229.
7. Petricoin EF 3rd, Hackett JL, Lesko LJ, Puri RK, Gutman SI, et al. 2002. Medical applications of microarray technologies: a regulatory science perspective. Nat Genet 32 Suppl:474-479.
8. Carr KM, Bittner M, Trent JM. 2003. Gene-expression profiling in human cutaneous melanoma. Oncogene 22:3076-3080.
9. Bertucci F, Viens P, Tagett R, Nguyen C, Houlgatte R, et al. 2003. DNA arrays in clinical oncology: promises and challenges. Lab Invest 83:305-316.
10. Honoré B, Østergaard M. 2003. Transcriptomics and proteomics: integration? In: Cooper DN, editor. Nature Encyclopedia of the Human Genome. London: Nature Publishing Group, p 579-584.
11. Gygi SP, Rochon Y, Franza BR, Aebersold R. 1999. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19:1720-1730.
12. Patterson SD, Aebersold RH. 2003. Proteomics: the first decade and beyond. Nat Genet 33 Suppl:311-323.
13. Fey SJ, Larsen PM. 2001. 2D or not 2D. Curr Opin Chem Biol 5:26-33.
14. Blackstock WP, Weir MP. 1999. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol 17:121-127.
15. O'Farrell PH. 1975. High-resolution two dimensional gel electrophoresis of proteins. J Biol Chem 250:4007-4021.
16. Klose J. 1975. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 26:231-243.
17. Klose J, Kobalz U. 1995. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 16:1034-1059.
18. O'Farrell PZ, Goodman HM, O'Farrell PH. 1977. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 12:1133-1141.
19. Celis JE, Rasmussen HH, Gromov P, Olsen E, Madsen P, et al. 1995. The human keratinocyte two-dimensional gel protein database (update 1995): Mapping components of signal transduction pathways. Electrophoresis 16:2177-2240.
20. Link AJ. Methods in Molecular Biology, Vol. 112, 2-D proteome analysis protocols. Totowa, New Jersey: Humana Press, 1999.
21. Görg A, Obermaier C, Boguth G, Harder A, Scheibe B, et al. 2000. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21:1037-1053.
22. Rabilloud T. 2002. Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2:3-10.
23. Hanash SM. 2000. Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status. Electrophoresis 21:1202-1209.
24. Blomberg A, Blomberg L, Norbeck J, Fey SJ, Larsen PM, et al. 1995. Interlaboratory reproducibility of yeast protein patterns analyzed by immobilized pH gradient two-dimensional gel electrophoresis. Electrophoresis 16:1935-1945.
25. Bjellqvist B, Basse B, Olsen E, Celis JE. 1994. Reference points for comparisons of two-dimensional maps of proteins from different human cell types defined in a pH scale where isoelectric points correlate with polypeptide compositions. Electrophoresis 15:529-539.
26. Nawrocki A, Larsen MR, Podtelejnikov AV, Jensen ON, Mann M, et al. 1998. Correlation of acidic and basic carrier ampholyte and immobilized pH gradient two-dimensional gel electrophoresis patterns based on mass spectrometric protein identification. Electrophoresis 19:1024-1035.
27. Görg A, Boguth G, Obermaier C, Weiss W. 1998. Two-dimensional electrophoresis of proteins in an immobilized pH 4-12 gradient. Electrophoresis 19:1516-1519.
28. Wildgruber R, Harder A, Obermaier C, Boguth G, Weiss W, et al. 2000. Towards higher resolution: two-dimensional electrophoresis of Saccharomyces cerevisiae proteins using overlapping narrow immobilized pH gradients. Electrophoresis 21:2610-2616.
29. Righetti PG, Bossi A. 1997. Isoelectric focusing in immobilized pH gradients: recent analytical and preparative developments. Anal Biochem 247:1-10.
30. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez JC. 2000. The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis 21:1104-1115.
31. Hoving S, Voshol H, van Oostrum J. 2000. Towards high performance two-dimensional gel electrophoresis using ultrazoom gels. Electrophoresis 21:2617-2621.
32. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, et al. 1996. Laser capture microdissection. Science 274:998-1001.
33. Cordwell SJ, Nouwens AS, Verrills NM, Basseal DJ, Walsh BJ. 2000. Subproteomics based upon protein cellular location and relative solubilities in conjunction with composite two-dimensional electrophoresis gels. Electrophoresis 21:1094-1103.
34. Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, et al. 1998. Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis 19:837-844.
35. Zuo X, Speicher DW. 2000. A method for global analysis of complex proteomes using sample prefractionation by solution isoelectrofocusing prior to two-dimensional electrophoresis. Anal Biochem 284:266-278.
36. Garreis JI, McLaughlin CS, Warner JR, Futcher B, Latter GI, et al. 1997. Proteome studies of Saccharomyces cerevisiae: identification and characterization of abundant proteins. Electrophoresis 18:1347-1360.
37. Rabilloud T, Blisnick T, Heller M, Luche S, Aebersold R, et al. 1999. Analysis of membrane proteins by two-dimensional electrophoresis: comparison of the proteins extracted from normal or Plasmodium falciparum-infected erythrocyte ghosts. Electrophoresis 20:3603-3610.
38. Santoni V, Kieffer S, Desclaux D, Masson F, Rabilloud T. 2000. Membrane proteomics: use of additive main effects with multiplicative interaction model to classify plasma membrane proteins according to their solubility and electrophoretic properties. Electrophoresis 21:3329-3344.
39. Wissing J, Heim S, Flohe L, Bilitewski U, Frank R. 2000. Enrichment of hydrophobic proteins via Triton X-114 phase partitioning and hydroxyapatite column chromatography for mass spectrometry. Electrophoresis 21:2589-2593.
40. Rabilloud T, Adessi C, Giraudel A, Lunardi J. 1997. Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 18:307-316.
41. Chevailet M, Santoni V, Poinas A, Rouquie D, Fuchs A, et al. 1998. New zwitterionic detergents improve the analysis of membrane proteins by two-dimensional electrophoresis. Electrophoresis 19:1901-1909.
42. Patton WF. 2000. A thousand points of light: the application of fluorescence detection technologies to two-dimensional gel electrophoresis and proteomics. Electrophoresis 21:1123-1144.
43. Switzer RC 3rd, Merril CR, Shifrin S. 1979. A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem 98:231-237.
44. Shevchenko A, Wilm M, Vorm O, Mann M. 1996. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 68:850-858.
45. Mørtz E, Krogh TN, Vorum H, Görg A. 2001. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 1:1359-1363.
46. Syrovy I, Hodny Z. 1991. Staining and quantification of proteins separated by polyacrylamide gel electrophoresis. J Chromatogr 569:175-196.
47. Steinberg TH, Jones LJ, Haugland RP, Singer VL. 1996. SYPRO orange and SYPRO red protein gel stains: one-step fluorescent staining of denaturing gels for detection of nanogram levels of protein. Anal Biochem 239:223-237.
48. Yan JX, Harry RA, Spibey C, Dunn MJ. 2000. Postelectrophoretic staining of proteins separated by two-dimensional gel electrophoresis using SYPRO dyes. Electrophoresis 21:3657-3665.
49. Gygi SP, Aebersold R. 1999. Absolute quantitation of 2-D protein spots. Methods Mol Biol 112:417-421.
50. Berggren K, Chernokalskaya E, Steinberg TH, Kemper C, Lopez MF, et al. 2000. Background-free, high sensitivity staining of proteins in one- and two-dimensional sodium dodecyl sulfate-polyacrylamide gels using a luminescent ruthenium complex. Electrophoresis 21:2509-2521.
51. Ünlü M, Morgan ME, Minden JS. 1997. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18:2071-2077.
52. Honoré B, Vorum H, Pedersen AE, Buus S, Claësson MH. 2004. Changes in protein expression in p53 deleted spontaneous thymic lymphomas. Exp Cell Res 295:91-101.
53. Zhou G, Li H, DeCamp D, Chen S, Shu H, et al. 2002. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics 1:117-124.
54. Van den Bergh G, Clerens S, Cnops L, Vandesande F, Arckens L. 2003. Fluorescent two-dimensional difference gel electrophoresis and mass spectrometry identify age-related protein expression differences for the primary visual cortex of kitten and adult cat. J Neurochem 85:193-205.
55. Gharbi S, Gaffney P, Yang A, Zvelebil MJ, Cramer R, et al. 2002. Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics 1:91-98.
56. Shaw J, Rowlinson R, Nickson J, Stone T, Sweet A, et al. 2003. Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics 3:1181-1195.
57. Tonge R, Shaw J, Middleton B, Rowlinson R, Rayner S, et al. 2001. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1:377-396.
58. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, et al. 2003. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3:36-44.
59. Vuong GL, Weiss SM, Kammer W, Priemer M, Vingron M, et al. 2000. Improved sensitivity proteomics by postharvest alkylation and radioactive labelling of proteins. Electrophoresis 21:2594-2605.
60. Shively JE. 2000. The chemistry of protein sequence analysis. EXS 88:99-117.
61. Gromov PS, Østergaard M, Gromova I, Celis JE. 2002. Human proteomic databases: a powerful resource for functional genomics in health and disease. Prog Biophys Mol Biol 80:3-22.
62. Celis JE, Gromov P. 1999. 2D protein electrophoresis: can it be perfected? Curr Opin Biotechnol 10:16-21.
63. Mann M, Hendrickson RC, Pandey A. 2001. Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem 70:437-473.
64. Aebersold R, Mann M. 2003. Mass spectrometry-based proteomics. Nature 422:198-207.
65. Lin D, Tabb DL, Yates JR. 2003. Large-scale protein identification using mass spectrometry. Biochim Biophys Acta 1646:1-10.
66. Cotter RJ. 1989. Time-of-flight mass spectrometry: an increasing role in the life sciences. Biomed Environ Mass Spectrom 18:513-532.
67. Marshall AG, Hendrickson CL, Jackson GS. 1998. Fourier transform ion cyclotron resonance mass spectrometry: a primer. Mass Spectrom Rev 17:1-35.
68. Morris HR, Paxton T, Dell A, Langhorne J, Berg M, et al. 1996. High sensitivity collisionally-activated decomposition tandem mass spectrometry on a novel quadrupole/orthogonal-acceleration time-of-flight mass spectrometer. Rapid Commun Mass Spectrom 10:889-896.
69. Cavdar Koc E, Blackburn K, Burkhart W, Spremulli LL. 1999. Identification of a mammalian mitochondrial homolog of ribosomal protein S7. Biochem Biophys Res Commun 266:141-146.
70. Edmondson RD, Vondriska TM, Biederman KJ, Zhang J, Jones RC, et al. 2002. Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS. Mol Cell Proteomics 1:421-433.
71. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, et al. 1999. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 17:676-682.
72. Washburn MP, Wolters D, Yates JR 3rd. 2001. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19:242-247.
73. Hayes BK, Greis KD, Hart GW. 1995. Specific isolation of O-linked N-acetylglucosamine glycopeptides from complex mixtures. Anal Biochem 228:115-122.
74. Ficarro SB, McCleland ML, Stukenberg PT, Burke DJ, Ross MM, et al. 2002. Phosphoproteome analysis by mass spectrometry and its-application to Saccharomyces cerevisiae. Nat Biotechnol 20:301-305.
75. Mann M, Ong SE, Grønborg M, Steen H, Jensen ON, et al. 2002. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol 20:261-268.
76. Spahr CS, Susin SA, Bures EJ, Robinson JH, Daws MT, et al. 2000. Simplification of complex peptide mixtures for proteomic analysis: reversible biotinylation of cysteinyl peptides. Electrophoresis 21:1635-1650.
77. Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, et al. 2003. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol 21:566-569.
78. Tang N, Tornatore P, Weinberger SR. 2004. Current developments in SELDI affinity technology. Mass Spectrom Rev 23:34-44.
79. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, et al. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17:994-999.
80. 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal Chem 73:2836-2842.
81. Oda Y, Huang K, Cross FR, Cowburn D, Chait BT. 1999. Accurate quantitation of protein expression and site-specific phosphorylation. Proc Natl Acad Sci USA 96:6591-6596.
82. Aebersold R. 2003. Constellations in a cellular universe. Nature 422:115-116.
83. Aebersold R, Cravatt BF. 2002, Proteomics - advances, applications and the challenges that remain. Trends Biotechnol 20:31-32.
84. MacBeath G. 2002. Protein microarrays and proteomics. Nat Genet 32 Suppl:526-532.
85. Zhu H, Snyder M. 2003. Protein chip technology. Curr Opin Chem Biol 7:55-63.
86. Lee YS, Mrksich M, 2002. Protein chips: from concept to practice. Trends Biotechnol 20:314-318.
87. Elia G, Silacci M, Scheurer S, Scheuermann J, Neri D. 2002. Affinity-capture reagents for protein arrays. Trends Biotechnol 20:319-322.
88. Silzel JW, Cercek B, Dodson C, Tsay T, Obremski RJ. 1998. Mass-sensing, multianalyte microarray immunoassay with imaging detection. Clin Chem 44:2036-2043.
89. Schweitzer B, Roberts S, Griniwade B, Shao W, Wang M, et al. 2002. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol 20:359-365.
90. Nielsen UB, Cardone MH, Sinskey AJ, MacBeath G, Sorger PK. 2003. Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc Natl Acad Sci USA.
91. Haab BB, Dunham MJ, Brown PO. 2001. Protein microarrays for highly parallel detection arid quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2: RESEARCH0004.1-0004.13.
92. Sreekumar A, Nyati MK, Varambally S, Barrette TR, Ghosh D, et al. 2001. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res 61:7585-7593.
93. Knezevic V, Leethanakul C, Bichsel VE, Worth JM, Prabhu VV, et al. 2001. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1:1271-1278.
94. Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, et al. 2001. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20:1981-1989.
95. Joos TO, Schrenk M, Hopfl P, Kroger K, Chowdhury U, et al. 2000. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 21:2641-2650.
96. Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, et al. 2002. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 16:414-416.
97. Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, et al. 2001. Global analysis of protein activities using proteome chips. Science 293:2101-2105.
98. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR. 1994. Making antibodies by phage display technology. Annu Rev Immunol 12:433-455.
99. Holt LJ, Enever C, de Wildt RM, Tomlinson IM. 2000. The use of recombinant antibodies in proteomics. Curr Opin Biotechnol 11:445-449.
100. Hoogenboom HR, de Bruine AP, Hufton SE, Hoet RM, Arends JW, et al. 1998. Antibody phage display technology and its applications. Immunotechnology 4:1-20.
101. de Wildt RM, Mundy CR, Gorick BD, Tomlinson IM. 2000. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol 18:989-994.
102. Mintz PJ, Kim J, Do KA, Wang X, Zinner RG, et al. 2003. Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol 21:57-63.
103. Fields S, Song O. 1989. A novel genetic system to detect protein-protein interactions. Nature 340:245-246.
104. Putz U, Skehel P, Kuhl D. 1996. A tri-hybrid system for the analysis and detection of RNA-protein interactions. Nucleic Acids Res 24:4838-4840.
105. Alexander MK, Bourns BD, Zakian VA. 2001. One-hybrid systems for detecting protein-DNA interactions. Methods Mol Biol 177:241-259.
106. Hengen PN. 1997. False positives from the yeast two-hybrid system. Trends Biochem Sci 22:33-34.
107. Licitra EJ, Liu JO. 1996. A three-hybrid system for detecting small ligand-protein receptor interactions. Proc Natl Acad Sci USA 93:12817-12821.
108. Vidal M, Legrain P. 1999. Yeast forward and reverse 'n'-hybrid systems. Nucleic Acids Res 27:919-929.
109. Manning BD, Cantley LC. 2002. Hitting the target: emerging technologies in the search for kinase substrates. Science's STKE 2002:PE49.